Who
Tempus AI, Inc.
10% owner
Company insider
Files Form 4 as: 10% owner, Personalis.
In numbers
- Trades disclosed
- 29
- Buys
- 11
- Sells
- 0
- Bought
- $23.2M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Aug 2024
- Last trade
- 22 Dec 2025
- Last filed
- 13 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $250K28,000 at $8.93 | filing |
| 22 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $250K28,000 at $8.93 | filing |
| 19 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K29,641 at $8.39 | filing |
| 19 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K29,641 at $8.39 | filing |
| 18 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K31,430 at $7.91 | filing |
| 18 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K31,430 at $7.91 | filing |
| 17 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K31,650 at $7.86 | filing |
| 17 Dec 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K31,650 at $7.86 | filing |
| 25 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $98K9,712 at $10.08 | filing |
| 25 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $153K13,888 at $11.00 | filing |
| 25 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $98K9,712 at $10.08 | filing |
| 25 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $153K13,888 at $11.00 | filing |
| 24 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K25,225 at $9.87 | filing |
| 24 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K25,225 at $9.87 | filing |
| 21 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $88K9,900 at $8.84 | filing |
| 21 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $162K16,599 at $9.74 | filing |
| 21 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $88K9,900 at $8.84 | filing |
| 21 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $162K16,599 at $9.74 | filing |
| 20 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K28,827 at $8.63 | filing |
| 20 Nov 2025filed 13 Feb 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Bought | $249K28,827 at $8.63 | filing |
News
Tempus AI, Inc.: Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLCfinanznachrichten.de · 19 Oct 2026Tempus AI, Inc.: Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026finanznachrichten.de · 1 Oct 2026Personalis, Inc.: Personalis NeXT Personal Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026PSNL · finanznachrichten.de · 21 Oct 2026
2 headlines in the last 90 days name Tempus AI, Inc.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.